Court Voids Antiretroviral Tender Awards, Orders Redo
The Pretoria High Court ruled the awards for two items in the R15.5 billion national antiretroviral tender unlawful and unconstitutional.
Updated on Nov. 18, 2026 in Healthcare

Live Poll
Do you trust government drug tenders to be awarded fairly?
The Pretoria High Court found the awards for Item 13 and Item 23 of South Africa's R15.5 billion national antiretroviral tender unlawful and unconstitutional, and ordered them redone within 120 days. The case was brought by Cipla Medpro Manufacturing, and the judgment was issued by Acting Judge Graham Girdwood.
Why it matters
The ruling found serious irregularities in how local manufacturing and HDI points were allocated, raising questions about competition in a tender that supplies medicines to the public health system. The Economic Freedom Fighters (EFF) has demanded the resignation of Health Minister Aaron Motsoaledi with immediate effect.
The judgment concerns the R12.6 billion TLD portion of the R15.5 billion tender, with Cipla receiving three minor awards worth between R214 million and R215 million. The court has ordered the Department to redo the awards within 120 days, and whether the replacement process produces different outcomes remains unknown.
The players
Aaron Motsoaledi
South Africa's Minister of Health, whose department ran the national antiretroviral tender and who was ordered to pay costs in the case.
Cipla Medpro Manufacturing
A pharmaceutical manufacturer that brought the case challenging the tender awards and received three minor awards.
Avacare Health Group
A South African healthcare group whose subsidiaries Barrs Pharmaceuticals and Innovata were stripped of HDI points by the court.
Economic Freedom Fighters (EFF)
A South African opposition political party that demanded Motsoaledi's resignation and called for an SIU investigation into the tender.
The details
The court found that Innovata Pharmaceuticals and Viatris Healthcare relied on an Isando manufacturing site licence that had expired before tender closure. It also ordered HDI points stripped from Barrs Pharmaceuticals and Innovata, both subsidiaries of Avacare Health Group, for failing to prove ownership, and ordered Motsoaledi and his then Director General to pay Cipla's costs. Hetero Drugs' application challenging its own exclusion was dismissed.
Timeline
20 October: Pretoria High Court judgment found the tender awards unlawful.
19 February: Portfolio Committee statement echoed EFF concerns about the tender.
Within 120 days of the judgment: Deadline for the Department to redo the Item 13 and Item 23 awards.
90 days after new awards: Current suppliers continue delivering to avoid shortages.
Market Landscape
The judgment sits within South Africa's use of HDI points and local-manufacturing criteria in public procurement, which are designed to broaden ownership of the economy. The court's finding that common Avacare ownership and expired licences were not properly checked shows how these preferences can be tested in large state tenders.
Current suppliers will continue delivering antiretroviral medicines for 90 days after new awards, which the Department says is meant to avoid shortages for patients on treatment. Whether the replacement awards change which companies supply these medicines will determine any longer-term effect on availability.
The takeaway
Public tenders for essential medicines depend on ownership and licensing checks being applied correctly, and this ruling shows how gaps in those checks can force a costly re-tender. Readers tracking the HIV treatment supply should watch the Department's replacement awards within the 120-day window.
What happens next
The Department of Health must redo the Item 13 and Item 23 awards within 120 days of the 20 October judgment, and current suppliers will keep delivering for 90 days after new awards are made.
Further reading
For related coverage, see Healthcare news on South Africa's medicine supply and public health procurement.
Source note: This article includes information reported by African News Agency.
Live Poll
Do you trust government drug tenders to be awarded fairly?






